MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections

  • Ryan M. McCormack
    Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
  • Eva P. Szymanski
    Laboratory of Clinical Infectious Diseases, NIAID, NIH,
  • Amy P. Hsu
    Laboratory of Clinical Infectious Diseases, NIAID, NIH,
  • Elena Perez
    Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
  • Kenneth N. Olivier
    Cardiovascular and Pulmonary Branch, NHLBI, NIH, Bethesda, Maryland, USA.
  • Eva Fisher
    Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
  • E. Brook Goodhew
    Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
  • Eckhard R. Podack
    Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
  • Steven M. Holland
    Laboratory of Clinical Infectious Diseases, NIAID, NIH,

書誌事項

公開日
2017-04-20
DOI
  • 10.1172/jci.insight.89635
公開者
American Society for Clinical Investigation

説明

<jats:p> Perforin-2 is a highly conserved pore-forming protein encoded by macrophage expressed gene 1 ( <jats:italic>MPEG1</jats:italic> ). A number of studies have shown that Perforin-2–deficient mice are unable to survive following a bacterial challenge that is nonlethal in WT mice. There is also recent evidence that <jats:italic>Mpeg1</jats:italic> <jats:sup>+/–</jats:sup> heterozygous mice display an intermediate killing ability compared with <jats:italic>Mpeg1</jats:italic> WT and <jats:italic>Mpeg1</jats:italic> <jats:sup>–/–</jats:sup> mice. Despite these in vivo findings, to date, no perforin-2 deficiencies have been associated with human disease. Here, we report four patients with persistent nontuberculous mycobacterial infection who had heterozygous <jats:italic>MPEG1</jats:italic> mutations. In vitro, neutrophils, macrophages, and B cells from these patients were unable to kill <jats:italic>Mycobacterium avium</jats:italic> as efficiently as normal controls. CRISPR mutagenesis validated the deleterious antibacterial activity of these mutations. These data suggest that perforin-2 haploinsufficiency may contribute to human susceptibility to infections with intracellular bacteria. </jats:p>

収録刊行物

  • JCI Insight

    JCI Insight 2 (8), e89635-, 2017-04-20

    American Society for Clinical Investigation

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ